Skip to Main Content

Paper Details

Blood GFAP as an emerging biomarker in brain and spinal cord disorders.
Nat Rev Neurol
189
2022
Blood, GFAP, TBI, acute neurological diseases, blood, blood GFAP, brain and spinal cord diseases, brain and spinal cord disorders, carboxy, glial fibrillary acidic protein, multiple sclerosis, neuroaxonal, neurological diseases, neurological disorders, stroke, traumatic brain injury, ubiquitin carboxy-terminal hydrolase L1
Author NameAffiliation
John K YueUniversity of California San Francisco (UCSF)
Axel PetzoldThe National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Moorfields Eye Hospital
Axel Petzold
Geoffrey T ManleyUniversity of California San Francisco (UCSF)
Geoffrey T ManleyUniversity of California San Francisco (UCSF)
  • 1 - 5

Datasets

Release 1.2